comparemela.com

Latest Breaking News On - Assembly biosciences stock trading over - Page 1 : comparemela.com

Cautious Optimism For Bluebird Bio s Sickle Cell Therapy: Analyst Sees Financial Challenges - bluebird bio (NASDAQ:BLUE)

Cantor Fitzgerald initiated coverage on Bluebird Bio Inc (NASDAQ: BLUE), saying sickle cell disorder (SCD) has been a hotbed of development for genetic medicines as the company's lovo-cel marches towards the U.S. market. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.